Novo Integrated Sciences
NVOS
$0.57
Share price
4.07%
Change (1 day)
182.80%
Change (1 year)
Categories
Operating Margin for Novo Integrated Sciences (NVOS)
Operating Margin as of May 2024 (TTM): -281.71%
According to Novo Integrated Sciences's latest financial reports and stock price the company's current Operating Margin is -281.71%. At the end of 2021 the company had an Operating Margin of -46.27%.
Operating Margin history for Novo Integrated Sciences from 2018 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -46.27% | -23.7% |
| 2020 | -60.65% | 3049.79% |
| 2019 | -1.93% | -88.97% |
| 2018 | -17.46% | 1661.77% |
| 2017 | -0.99% | -140.15% |
| 2016 | 2.47% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Select Medical Holdings SEM | 8.05% | -102.86% | 🇺🇸 USA |
 HealthSouth
EHC | 12.14% | -104.31% | 🇺🇸 USA |
 Novo Integrated Sciences NVOS | -281.71% | 0.00% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.